Does ROMIPLOSTIM Cause Basal cell carcinoma? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Basal cell carcinoma have been filed in association with ROMIPLOSTIM (Nplate). This represents 0.1% of all adverse event reports for ROMIPLOSTIM.
7
Reports of Basal cell carcinoma with ROMIPLOSTIM
0.1%
of all ROMIPLOSTIM reports
2
Deaths
5
Hospitalizations
How Dangerous Is Basal cell carcinoma From ROMIPLOSTIM?
Of the 7 reports, 2 (28.6%) resulted in death, 5 (71.4%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMIPLOSTIM. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does ROMIPLOSTIM Cause?
Off label use (1,027)
Platelet count decreased (892)
Platelet count abnormal (703)
Drug ineffective (513)
Thrombocytopenia (369)
Headache (359)
Death (356)
Product storage error (344)
Fatigue (251)
Circumstance or information capable of leading to medication error (238)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which ROMIPLOSTIM Alternatives Have Lower Basal cell carcinoma Risk?
ROMIPLOSTIM vs ROMOSOZUMAB
ROMIPLOSTIM vs ROMOSOZUMAB-AQQG
ROMIPLOSTIM vs ROPEGINTERFERON ALFA-2B-NJFT
ROMIPLOSTIM vs ROPINIROLE
ROMIPLOSTIM vs ROPIVACAINE